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Sharing leadership for diffusion of innovation in professionalized settings 
Graeme Currie and Dimitrios Spyridonidis 
 
 
Abstract 
Innovation often flourishes in organizational pockets, but then fails to diffuse more widely. 
This represents a particular global challenge in healthcare where demands of an ageing 
population with increasing long-term conditions need to be addressed in the face of financial 
constraints. Shared leadership to support diffusion of innovation may offer a panacea for the 
challenge. Our study shows how changing configurations of shared leadership support 
diffusion and adaption of innovation. Managers remain important actors for the mandate and 
resourcing of innovation but, over time, powerful professionals, specifically doctors come to 
the fore, to engage their peers and influence resource allocation. Nurses complement doctors’ 
leadership efforts around engagement of frontline professionals and in adapting innovation to 
local context. Significant contingencies in shaping shared leadership for diffusion and 
adaption of innovation are: organizational financial performance; whether nurses enact 
hybrid leadership roles; whether organization is hierarchical or collaborative. Theoretically, 
by focusing upon leadership configuration in the process of diffusion of innovation, our study 
renders visible practices of shared leadership, interdependency of hierarchical managerial or 
professional influence, its effect upon innovation diffusion and contingencies that underpin 
this. 
 
Keywords 
healthcare organisations, innovation, leadership, management, public management 
  
  
Introduction 
Innovation management research increasingly emphasizes interest in diffusing promising 
innovation across national, regional, and organizational boundaries, however efforts to 
promote and diffuse innovation across such boundaries often fail (Delre et al., 2010). 
Leadership is deemed crucial for diffusion of innovation, we need to better understand its 
dynamics (Battilana et al., 2010; De Vries Bekkers and Tummers, 2016; Fitzgerald et al., 
2002), specifically as it affects adaption of innovation as it diffuses (Hartley and Benington, 
2010; Rosing, Frese and Bausch, 2011).  
First, the dynamics of leadership around diffusion of innovation across time represents a 
research gap, requiring a more longitudinal research design (Chreim 2015; Gronn, 2015; 
White, Currie and Lockett, 2016).  Second, addressing a need for more contextualized 
understanding of leadership dynamics (Liden and Antonakis, 2009), we lack insight into the 
dynamics of leadership for diffusion of innovation in professionalized contexts, notably 
healthcare (Fitzgerald et al., 2002, 2013; Greenhalgh et al., 2004; Hartley and Benington, 
2010; Martin et al., 2013). On the one hand, in professionalized contexts, diffusion of 
innovation requires shared leadership, “a dynamic, interactive influence among individuals 
and groups for which the objective is to lead one another to the achievement of group or 
organizational goals or both” (Pearce and Conger, 2003:1).  On the other hand, 
professionalized contexts, such as healthcare, are characterized by managerial and 
professional hierarchy that is likely to concentrate rather than spread leadership (Currie and 
Lockett, 2011; Denis, Langley and Sergi, 2012). Such a setting is likely to illuminate 
dynamics of interaction between shared and hierarchical leadership (Holm and Fairhurst, 
2018) as innovation diffuses and adapts to context.    
Empirically, our study examines leadership for diffusion of twelve innovations in a large 
city healthcare system, all of which encompass a new way of delivering a service (commonly 
  
an attempt to move part of a service out of the hospital into community settings) and new 
organizational processes underpinning this (such as new roles developed to offer the service 
in community settings). That is, the innovations we examine combine service innovation and 
process innovation (De Vries, Bekkers and Tummers, 2016; Hartley, 2005). We conceive 
innovation as processual, encompassing a temporal element through which new practices, 
processes, or structures are introduced, sustained, and scaled up by key actors to improve the 
organization’s performance (Van de Ven, 1986; Van de Ven and Poole, 2000).  Empirically 
within our study, a central management team within a citywide R&D organization provide 
resource and other support to encourage a pilot innovation within one hospital and related 
healthcare providers focused upon a range of long-term health conditions for which mortality 
rates are increasing (such as respiratory disease), which they then seek to diffuse to other 
healthcare providers across the city, and then nationally in some cases. In initiating 
innovation and its diffusion, R&D managers interact with two main professional groups 
(doctors  and nurses) and their respective clinical leaders. Our study focuses on leadership 
interactions of managers, doctors and nurses, encompassing 210 interviews and 56 hours 
observation over a three year period as twelve innovations diffuse.  
Our manuscript is structured as follows. First, we discuss challenges of innovation 
diffusion in healthcare settings including likely adaption of the original innovation, and 
shared leadership necessary to support this (Denis, Langley and Sergi, 2012) . While we 
highlight some highly relevant studies (Fitzgerald et al., 2002, 2013; Greenhalgh et al., 2004; 
Martin et al., 2013), we note limited insight into leadership dynamics over time and practices 
enacted by leaders to support diffusion and adaption of innovation in healthcare settings.  
Second, we introduce the context for our study, our data gathering techniques and data 
analysis. Third, we present our empirical analysis of leadership practices for innovation 
diffusion across three groups of actors -- managers (without a clinical background), higher 
  
status professionals (doctors), lower status professionals (nurses) – structured by three phases 
of innovation diffusion and adaption. Having summarized comparative cases, we focus upon 
our success case (Chronic Obstructive Pulmonary Disorder or COPD), following which we 
then derive comparative case analysis to draw out the contextual dimensions that underpin 
shared leadership for diffusion of innovation. In our conclusion, we summarize our empirical 
analysis, highlight our theoretical contribution, practical implications, and a need for further 
research. 
 
Leadership for diffusion of innovation in healthcare 
There is longstanding recognition that  diffusion of innovation is non-linear and complex 
(Robertson, Swan and Newell, 1996; Van de Ven et al., 1999; Wolfe, 1994). Innovation 
diffuses through social networks, and is adapted by actors as it does so, with professionals 
playing a key role, not least in healthcare settings. On the one hand, healthcare managers may 
want to ensure that diffusion of innovation remains faithful to its evidence-based origins, 
which determine its efficacy. On the other hand, as the original innovation diffuses it needs to 
‘fit’ the recipient organizational context to ensure its longer-term sustainability (Mathers, 
Taylor and Parry, 2014).  As innovation diffuses to other healthcare organizations, it needs to 
align with pre-existing organizational routines and frontline professional staff must be 
engaged in its implementation (Martin et al., 2013; Rodriguez et al., 2016). Professionals that 
adopt innovation are not passive recipients, but active participants in the alteration and 
customization of innovation as it moves from one organizational context to another (Ferlie et 
al., 2005; Fitzgerald et al., 2002; Kimberly and Evanisko, 1981). In a healthcare setting both 
managers and different professionals participate in and enact leadership focused upon 
diffusion and adaption of  innovation.   
  
Studies of innovation, during its early stages, privilege managers as initiators of 
innovation through creation of an organizational climate to support innovation (Mumford, 
2000; Mumford et al., 2002). Managers develop shared awareness of organizational policies, 
practices, and procedures for innovation (Anderson and West, 1998), enable innovative 
endeavour by identifying and defining problems worth pursuing, create a context that 
encourages multiple actors to work together in generating viable ideas, and manage the 
context of idea development and its implementation, to ensure that viable ideas are likely to 
be adopted in the marketplace (Jung et al., 2003; McNally, Durmusoglu and Calantone, 2013; 
Smith and Tushman, 2005); promote organizations’ innovation performance by inspiring and 
rewarding the open exchange of ideas, and reinforcing curiosity, risk taking and trying new 
things (Mumford, 2000; Slater, Mohr and Sengupta, 2014), mobilize evidence into practice 
(Fischer et al., 2016). However, such advocacy for managerial leadership underplays the role 
others may play in innovation, such as professionals, particularly during its diffusion when 
more pluralist leadership is necessary (Empson and Langley, 2015; Fitzgerald et al., 2013; 
Greenhalgh et al., 2004). 
There are a plethora of terms that capture pluralist leadership -- ‘super leadership’ (Sims 
and Lorenzi, 1992), ‘distributed leadership’ (Gronn, 2002) and ‘collective leadership’ (Denis 
et al., 2001). We suggest all these terms lie within the broad confines of ‘shared leadership’ 
(Pearce and Conger, 2003), within which strategic leadership roles are shared, with each 
member of a ‘leadership constellation’ playing a distinct role and all members working 
together harmoniously. Taking account of the critique of the limit upon the potential for any 
individual driving innovation through a complex organization, shared leadership assembles 
the necessary variety of skills, expertise, and sources of influence and legitimacy (Denis et 
al., 2012).  
Shared leadership, first, re-envisions the ‘who’ of leadership, with leadership representing 
  
a set of practices that can and should be enacted by actors at all levels, rather than a set of 
personal characteristics and attributes located in senior level managers. Second, it re-
envisions the ‘what’ of leadership through its emphasis upon social interactions around 
leadership influence; i.e. shared leadership is a group phenomenon with followers playing a 
role in influencing and creating leadership. Finally, shared leadership re-envisions the ‘how’ 
of leadership by focusing on the skills and abilities required to create conditions in which 
collective learning can occur (Pearce and Conger, 2003).  
There is a particular need for shared leadership in professionalized settings such as 
healthcare (Currie and Lockett 2011, Denis et al., 2012), where professional (rather than 
managerial) power and leadership influence is prevalent (White, Currie and Lockett, 2014, 
2016), specifically to drive innovation (Empson and Langley, 2015; Fitzgerald et al., 2013; 
Greenhalgh et al., 2004). Participation of clinical leaders, both in formal positions and 
exerting informal influence, alongside managers, is essential otherwise innovation does not 
diffuse outwards to practice (Denis, Lamothe and Langley, 2006). In such settings, leadership 
influence may be derived from different and perhaps conflicting resources; i.e. professional 
status and managerial accountability (Currie and Lockett, 2011). As a consequence, shared 
leadership is likely to interact with hierarchical leadership, with different actors enacting 
different leadership roles and practices to diffuse innovation (Holm and Fairhurst, 
forthcoming). 
Commonly, in healthcare, an executive manager may enact strategic leadership to initiate 
innovation with a focus upon creating a strategy for innovation. At the same time, another 
actor (e.g. a middle level leader with a professional background) may act as a linking pin 
between the strategic apex of the organisation and frontline professionals (Currie and Procter, 
2005; Burgess and Currie, 2013; Spyridonidis and Currie, 2016) to ensure professionals buy 
into the executive leader’s vision and strategic objectives as innovation develops. Finally, 
  
other actors that have stronger affiliation with professionals on the ground, may facilitate the 
implementation process by acting as champions of change (Dopson et al., 2002). In 
healthcare settings, opinion leaders or champions drawn from professional ranks, through 
leadership influence gleaned from their social ties, political skills, professional and personal 
authority and credibility, have a particular influence upon peers to diffuse  innovation 
(Fitzgerald et al., 2002; Greenhalgh et al, 2004; Hartley and Benington, 2010; Locock et al., 
2001). Innovation thus emerges as a result of shared leadership, linked to hierarchical 
managerial or professional influence, that must be performed in a particular sequence or in 
parallel (Spillane, 2005). However, empirical examples of such shared leadership effect are 
relatively absent. To re-ietrate our research concern, our study seeks to illuminate dynamics 
of shared leadership as innovation diffuses and adapts to context.    
 
Methods  
The empirical setting 
Our empirical study is set in the English National Health Service (NHS), which 
represents a propitious empirical site for study of leadership for innovation diffusion from 
which more generalizable insight can be gleaned (Buchanan et al., 2007; Fitzgerald et al., 
2013). In the English NHS as with global health systems generally, innovation diffusion has 
proved particularly challenging (Chaudoir, Duggan and Barr,  2013; Damschroder et al., 
2009; De Vries, Bekkers and Tummers, 2016; Greenhalgh et al., 2004; Herzlinger, 2006). In 
response to this, leadership has been offered as a panacea (Greenhalgh et al., 2004), with 
suggestions that leadership should be shared amongst professional and managerial actors 
(Martin et al., 2013). Healthcare systems globally are characterized by fluid and equivocal 
authority and subtle power (Denis et al., 1996; Currie and Suhomlinova, 2006), with a myriad 
of professions arranged in a hierarchy of status (Abbott, 1988). The English NHS is 
  
historically dominated by a powerful cadre of doctors, who control their performance by 
virtue of their specialist training, expertise and knowledge, to whom others, such as nurses 
and managers are subordinated (Currie and Procter 2005). Doctors’ leadership influence 
tends towards a more collegiate model, but one within which hierarchical leadership 
influence may be evident by senior doctors that represent ‘first amongst equals’ (Currie and 
Croft, 2015). Nurses represent the largest professional group moving into operational 
management positions in healthcare organizations (Buchanan et al., 2013).  Nurses enact 
leadership influence, but often only over their nursing peers, and in a more explicitly 
hierarchical way (Currie, Burgess & Hayton, 2015). They are commonly subordinated to 
doctors’ demands and so struggle to enact leadership influence over doctors (Currie and 
Lockett, 2011). Meanwhile managers attempt to exert leadership influence over doctors and 
nurses through a range of mechanisms, such as organizational strategy, business plans, 
human resource management, and performance management systems (Ferlie et al., 1996).  
The specific empirical setting for this research is a city wide R&D organization (Metro 
Healthcare Innovation [MHI]) within the English NHS that received five years’ government 
funding to implement a programme that initiated and diffused promising innovation into 
everyday practice (Cooksey, 2006). MHI was formally led by a leadership team, consisting of 
executive managers responsible for setting its strategic vision. The executive management 
leadership team put in place new structures, people and initiatives to encourage innovation 
projects oriented towards improving patient outcomes. 12 innovation projects addressing 
specific clinical problems were provided with funding and other support for 18 months to 
build innovation capacity and implement a local project. Following which, the aim was for 
successful local innovation to be diffused within the same city and potentially more widely to 
other healthcare economies over the next three and a half years. Each project was led by a 
nominated senior doctor and team membership was multidisciplinary, including other 
  
doctors, nurses (commonly with managerial responsibilities), and where relevant, other 
clinicians, such as pharmacists, psychologists, therapists. We gathered data from all 12 
innovation projects (and all of which helped inform our emerging analysis), however in our 
empirical presentation, we particularly focus in-depth upon one of these, the Chronic 
Obstructive Pulmonary Disease (COPD) project. The COPD project sustained over the five 
years of our research programme in a way particularly illuminating of our research concern 
about dynamics of leadership and its effect upon innovation diffusion and adaption. In 
summary, the COPD project diffused from its originating site to 15 other healthcare providers 
in the city and beyond. While it was intended to diffuse to 15 healthcare providers in the 
original plan, the expectation was the project would diffuse with fidelity to its original 
evidence base about the most effective care pathway and the most effective workforce 
reconfiguration. However, the intervention was adapted as it diffused, with doctors and 
nurses enacting leadership influence towards adaption. We detail these dynamics further 
below.    
 
Research design  
Examining dynamics of shared leadership often requires a process lens (Langley et 
al., 2013), with a temporal orientation towards understanding sequentialized moves 
(Fairhurst, 2017; Fairhurst and Uhl-Bein, 2012). To ‘zoom in’ on sequentialized moves 
related to the dynamics of leadership in innovation diffusion, we must look to the practice of 
leadership rather than focus upon traits or behaviours of particular individuals. A leadership-
as-practice view aligns with a focus upon shared leadership since it recognizes leadership is 
accomplished, emerges and unfolds in a co-ordinated effort by many participants through 
their day-to-day experiences (Raelin, 2016). To generate a process sensitive and 
sequentialized understanding of leadership dynamics around innovation diffusion, we 
  
adopted a longitudinal case-study design, initiating fieldwork in year two of the innovation 
programme by MHI and continuing fieldwork for three years, with qualitative methods and 
an interpretive approach to allow issues of importance to emerge from the stories that key 
stakeholders -- executive managers, doctors, nurses, other professionals -- told us in across 
our 12 cases. 
 
Data collection  
We examined 12 comparative cases, for which the data collection techniques are 
summarized in Table 1.  Data collection took place through face-to-face interviews with key 
informants, complemented by observations of strategic management meetings and evaluation 
of documentary evidence, such as meeting minutes (See Table One). In total, we conducted 
210 semi-structured interviews. We observed 56 hours of strategic meetings and educational  
workshops. These events involved executive managers, doctors, nurses, and other 
professionals. Periods of observation lasted between 1-8 hours at any time and included 
informal conversations with participants we were observing to clarify aspects of key 
leadership practices. Notes were taken during or immediately following such observations or 
conversations as appropriate. These fieldwork notes were encompassed within a case study 
database, alongside interview transcripts and documentation, and subjected to analysis as 
detailed below. All managers of the leadership team (12) were interviewed four times across 
the lifespan of the research (48 interviews). 40 doctors (some of whom were formally 
appointed as medical leaders, some on the frontline who emerged as medical leaders), and 27 
nurses (in a supporting role for doctors during innovation diffusion -- see empirical data 
below) were interviewed at least twice over the lifespan of the research, once during the 
initial 18 month funding period, and up to twice again after this period as attempts at scale up 
ensued (152 interviews).  A further 10 interviews were conducted with other professionals, 
  
where they enacted leadership roles, such as pharmacists involved in the medications 
management project. The latter were interviewed once. All interviews were fully transcribed. 
 
---------------------------------------------------------------------- 
 Insert Table 1 About Here 
---------------------------------------------------------------------- 
 
Our empirical findings regarding the dynamics of shared leadership for diffusion of 
innovation across the 12 comparative cases are set out in Table Two. These provide the 
springboard for in-depth presentation of a single empirical case of the COPD (Chronic 
Obstructive Pulmonary Disorder)  project within the 12 comparative cases, across which 
shared leadership for diffusion of innovation was the most extensive (in terms of the number 
of healthcare providers across which it diffused). As set out in Table 1, our analysis of the 
COPD project is derived from 32 face-to-face interviews with 19 key informants (in addition 
to those with MHI managers), 12 hours of workshop observations, and collection of 
documentation across three time periods in the COPD project: year 2 (12 interviews); year 3 
(10 interviews), and year 4 (10 interviews) of our research programme relating to leadership 
influence over the diffusion and adaption of the COPD innovation. Following our empirical 
presentation of the ‘success’ case of COPD, we derive comparative case analysis to identify 
contingencies that shape shared leadership for diffusion of innovation in our final empirical 
section. 
 
Data analysis  
Our detailed analysis of the longitudinal data set was developed through a process 
explanation that was time-sensitive through a temporal bracketing strategy, anchoring the 
  
data into three successive phases, which we identified on the basis of changes in the 
dynamics of shared leadership in the diffusion of innovation (Langley, 1999; Langley, 
Smallman, Tsoukas & Van de Ven, 2013). The unit of analysis was the leadership 
configuration or patterns of relationships across time (Gronn, 2009), and we track the 
dynamic of leadership configurations for innovation diffusion. 
We followed an abductive logic. Abductive reasoning is characterized by constant 
dialogue between theory and empirical findings, which involves an analytical strategy based 
on continuous formulation and iteration of questions and answers from literature to both 
focus and explain emerging findings (Alvesson & Kärreman, 2007; Locke, Golden-Biddle & 
Feldman, 2008; Mantere & Ketokivi, 2013). In exploring the dynamics of shared leadership 
in diffusing innovation across phases, we observed the significance of shared leadership and 
the emergence of three key actors -- executive managers, doctors and nurses -- who enacted 
discrete but complementary leadership roles that changed over time.  
Data analysis progressed in three stages, during which the level of analytical 
generalization was raised step by step (Yin, 2013). In the first stage, we examined each of the 
12 cases separately. After transcribing interviews, each of the two authors read the transcripts 
in conjunction with the other data to identify: leadership practices of key leadership actors 
and its timing in relation to diffusion and adaption of innovation. After which we discussed 
first-order coding (as we did with second and third order coding), particularly where there 
were differences in analysis, and achieved agreement about first-order codes. At the second 
stage, we moved to more theoretical codes and conducted our analysis in a cross-case 
manner. We elaborated theoretical concepts and their relationships, using a constant 
comparative method (Glaser & Strauss, 1967; Eisenhardt, 1989), contrasting findings across 
the 12 cases, to arrive at out final theorical interpretation as presented in our next section, 
empirical presentation. 
  
Empirical presentation 
Cross-case analysis  
We summarize leadership influence enacted by three sets of actors (managers, doctors, 
nurses) across all 12 comparative over time periods in Table 2 below across three years of 
analysis. We can delineate distinctive roles and practices for executive managers, doctors and 
nurses as they shared leadership to diffuse and adapt innovation.  
Executive managers created a supportive climate for innovation through their initial 
mandate and continuing resourcing for innovation and they supported capacity of 
professional staff to engage in innovation through an educational programme.  They could 
not per se incentivize engagement of professionals in innovation since they were located in 
an R&D organization, which was an overarching structure, but not a direct employer for staff, 
for the healthcare providers which their innovation programme impacted.   
Doctors facilitated diffusion of innovation outwards from its originating hospital to other 
healthcare providers in the city through actively promoting innovation to commissioners and 
so influencing resource allocation, presenting evidence-based innovation to their peers within 
professional networks as well as the educational programme, with their adopting medical 
peers then adapting the innovation as it spread. 
Nurses’ leadership role was one that followed that of doctors, and they also adapted the 
innovation to fit with local context and organizational routines as it diffused, and in so doing 
engaged frontline professionals in its implementation.  
Across the 12 cases we thus see leadership is shared across three groups of actors: 
executive managers, doctors, and nurses, with each playing a distinctive role in the diffusion 
of innovation. We detail the dynamics of shared leadership across these three groups and its 
effect upon diffusion and adaption of innovation through focusing upon the in-depth case of 
the COPD project, which of all the 12 cases was the innovation that diffused most 
  
extensively.  Between year 2 of our study and year 4 of our study the bundle of care 
constituting the COPD innovation diffused, albeit with adaption as detailed below, across 15 
healthcare providers in the city and beyond that our empirical study focuses upon.  
 
---------------------------------------------------------------------- 
 Insert Table 2 About Here 
-------------------------------------------------------------------- 
 
In-depth case: Chronic obstructive pulmonary disorder 
COPD leadership dynamics in Phase 1 (years 1‒2)  Examining the temporal 
dimension of leadership influence suggests executive managers’ leadership influence is 
particularly prominent in the first phase of innovation diffusion (Year 2), with doctors and 
nurses relatively absent. In this early phase, executive managers focused first upon mandating 
diffusion of innovation, with their efforts aimed less at clinicians and more at senior 
executives within potential adopting organizations.  
 
The key element is working with key stakeholders particularly those chief 
executives who aren’t buying into innovation at the moment, getting them 
up to speed with local innovations across the patch, communicating what we 
can do for them (MHI Manager 4). 
 
Second, executive managers enhanced capability of those professionals that aimed to 
drive innovation through the establishment of an educational programme. 
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Our overall aim is to support the implementation of tools that can support 
innovation through project management development, clinical leadership, 
improved performance and how you would go about introducing new 
knowledge into practice (MHI Manager 12). 
 
Finally, executive managers garnered resource to support innovation diffusion, with the 
focus of their attention upon commissioners (other managers) that planned and funded 
healthcare in the city.  
 
And we like being in a position… we need to look at the funding for that.  
Actually, we can put some… pump priming money into that, which we 
couldn’t do last year. Unfortunately we don’t have enough money in the 
budget to do it, so we have to get buy-in from our commissioners (MHI 
Manager 3). 
 
Doctors complemented the leadership efforts of executive managers through working 
with them to promote local innovation to commissioners to shape prospects for recurrent 
funding as it diffused in later years. 
 
As a result of getting the money from MHI, the other thing that’s been 
absolutely spectacular is we’ve been able to go along to the commissioners 
and say, here you are, this is the package, and we’ve got funding to make 
this happen. In the short term, you have got no cost implications, it’s here. 
This could be the template for lots of other innovation attempts” (Senior  
Doctor 9, COPD).   
  
Nurses were absent at this stage from the leadership configuration, however happy to 
accept doctors’ leadership in this matter, as a consequence of the latters’ position in 
professional hierarchy and their influence over other potential adopters. 
 
Once you get some passionate champions that they go to places and start 
talking about the great work that they’ve been doing, that’s where it really 
starts to kind of take off because you get other people saying well, actually I 
want to be doing that in my place too. But you do need, relatively high up 
respected doctors saying that (Specialist Nurse 1, COPD). 
 
As can be seen above, in this first phase, shared leadership was relatively parsimonious. 
As the diffusion of innovation gathered pace, shared leadership became more extensive.  
 
COPD leadership in Phase 2 (Year 3)   In phase two, those who diffused innovation 
required legitimacy, thus powerful doctors came to the fore. They particularly acted as 
champions to promote innovation to others, specifically their medical peers, through the 
educational programme set up by executive managers.  
 
I walked into the workshop meeting and they [medical leads of the COPD 
innovation] are advising us [other potential adopters] about how we can 
implement the innovation and asking us how can they help (Senior Doctor 3, 
COPD).    
 
Doctors promoted innovation to others, and with greater force in phase two, through 
building networks and creating momentum for diffusion amongst others in their professional 
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group.  
 
It has to do with developing networks of people who are willing to be 
involved across [name of the region], and to offer a degree of peer support to 
these people. The idea is that over the next few years we encompass people 
from all backgrounds, and enable them to be involved more in some of our 
research and development activities. Through doing this, our aim is to create 
a supportive network across [name of region], to really deliver this. I mean, 
you can only do so much on your own (Senior Doctor 5, COPD). 
 
In turn, the new adopting doctors in turn adapted the innovation as it diffused.  
 
Our high-level strategy was to be responsive and in terms of the detail of 
what we diffused, we responded to the challenges we faced in our local area, 
what was likely to work or not, and we adapted the original model 
considerably to fit the local situation (Senior Doctor 1, COPD). 
 
In this phase more charismatic leadership was evident from doctors.  
 
He was seen as the ‘first amongst equals’ in our ranks. Whenever I come out 
of a meeting with [name of the medical leader] I usually feel very energised 
and excited and as though anything’s possible because he has that kind of 
leadership personality” (Senior Doctor 2, COPD). 
 
  
Reflecting the specificities of a professionalized context, managers behaved 
“diplomatically” and stepped back a little from their leadership role, albeit they continued 
garnering resource across the course of our fieldwork. 
 
From the commissioning perspective, there are so many changes happening 
across the sectors? Is it this, that, and the other? Who do we need to 
influence changes every week, so it’s just keeping up with that. And then it’s 
about cultivating those relationships. The doctors rely on us for this (MHI 
Manager 3). 
 
Managers ceded leadership influence to champions drawn from the ranks of doctors. 
 
Through the leadership development programme and other interventions we 
[managers] initiated, we’re generating new knowledge about how you 
implement innovation.  Although you may have a great idea that works in 
one setting, how do you implement it across a piece?  We are contributing to 
that by giving staff the time to focus on innovation, to become skilled up in 
leadership of innovation with a practical project and to  sustain and roll out 
innovation across the piece, drawing in champions for innovation from 
junior, as well as senior, doctors. We work closely with the doctors to ensure 
innovation spread (MHI Manager 10). 
 
Doctors leading the diffusion of innovation recognized the importance of sharing 
leadership with executive managers. 
  
If you’ve got a senior executive lead there that is supporting you that can 
make the difference for you and your project. And because they were there 
and supported it, it made a huge difference in how everybody else looked at 
it. It made it more likely that your innovation spreads (Senior Doctor 2, 
COPD). 
 
Meanwhile, nurses both ensured the innovation aligned with organizational routines in 
the adopting hospital.  
 
They are all in a different organizational context and the COPD care 
processes start in a different state and need to reach different outcomes. That 
requires some quite significant innovation adjustment in order to be suitable 
to the context, so, yes, that has been my role (Specialist Nurse 2, COPD). 
 
And worked with doctors to adapt the innovation as they did so. 
 
It’s a tightrope between what producers of the new service model thinks 
needs to be done, what the doctors think needs to be done and what national 
policies encourage. We do this bit, aligning local efforts and national 
mandates (Specialist Nurse 3, COPD). 
 
In summary, at the end of phase two, we see leadership is shared more widely from 
managers to doctors and nurses. This was a trend that continued in phase 3. 
 
  
COPD leadership in Phase 3 (Year 4)  In phase 3, doctors’ leadership efforts 
focused upon building networks through which evidence and best practice were presented: 
 
I’m rather fond of the idea of boundary spanning, that if you want two 
different worlds to speak to each other you need someone who is fluent in 
both languages and got their own kind of microclimate around them of 
followers, and so on. So, I hunt around for people who show those 
sensitivities to be able to speak more than one language, who are natural 
networkers, and I pull them in (Senior Doctor 3, COPD). 
 
 Following the development of medical networks to diffuse evidence and best practice 
around the COPD innovation, doctors other than those that initiated the innovation were 
further drawn into enacting leadership influence. Such leadership influence orientated 
towards adaption of the original innovation when moving the innovation across clinical areas; 
for example, the innovative approach in COPD was one picked up by doctors concerned with 
heart failure.  
 
We conducted another project in heart failure and we arranged for [names of 
heart failure consultants] to come and meet with our consultants. Both 
projects were looking into the bundle of care relating to the pathway for 
patient discharge so the aim was to see whether the COPD bundle could be 
adapted to treat heart failure patients in the same way. Their lead consultants 
adapted our bundle of care, and led its spread into heart failure (Senior 
Doctor 5, COPD) 
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Leadership influence by nurses orientated towards adaption was also evident when the 
COPD innovation crossed healthcare settings. 
 
We crossed into community care, and engaged a large community care 
organization. So I’m dealing with community teams, who may not always 
understand the process of an acute hospital, and their processes are very 
different. Their priorities are very different. So, the community care nurses 
have worked to adapt our innovation to fit with their practices, a process in 
which our original bundle of care has  changed four times, The nurses 
explain to their frontline colleagues as they engage them in the change, 
‘we’re adding this because, we’re changing this because, we’re taking this 
out because’ (Senior Doctor 11, COPD). 
 
Meanwhile, managers’ leadership influence in this phase of innovation diffusion 
orientated even more towards a diplomat stance, as they ceded leadership influence to 
doctors.  
 
We cede responsibility for innovation to medical leaders, but provide 
support for their projects, specifically through supporting leadership 
development for innovation. The result is sharing of leadership extending to 
many, beyond senior doctors with junior doctors now emerging as 
champions for innovation (MHI Manager 7). 
 
At the same time, managers sought to assure resources to sustain and diffuse the 
COPD innovation.  
  
 
Engaging our commissioners is increasingly important in the current 
financial environment. We have been using the strap-line ‘more health for 
the money’ to persuade them to release budget for the COPD service. We 
bring together other relevant agencies and partners that can help us assure 
continued resourcing (MHI Manager 9). 
 
Managers were reliant upon doctors to support their leadership efforts to influence 
commissioners to release resource. 
 
The money from MHI initiated the innovation, but to sustain and diffuse it 
requires recurrent funding from commissioners, whom we have approached 
to say, ‘here you are, this is the package, we have made it happen. In the 
short term, you have got no cost implications, it’s here. This could be the 
template for lots of other innovation attempts’. Following which, they 
supported the roll out of our COPD intervention (Senior Doctor 19, 
COPD).   
 
Doctors appeared to have greater legitimacy with commissioners when it came to 
resourcing matters, “at the end of the day, they know the detail of clinical context 
and the specificities of care, so we best step back” (MHI Manager 3). 
Nevertheless, even as they took up more significant leadership roles, doctors 
recognized the need to share leadership with managers. 
Two sets of people are important to the project’s spread. Managers have 
knowledge, through their professional networks, of the increasing 
  
importance of COPD as a policy priority at national level, while clinical 
project leads have excellent knowledge of the problems and priorities of 
delivering respiratory care within the local healthcare economy (Senior 
Doctor 1, COPD). 
 
So, that’s been it’s been really reassuring that there is this continual buy-in 
from management. We can only be successful if we’re useful to our 
stakeholders and engage different managers at many levels including, Chief 
Executives, Medical Directors, Finance Directors (Senior Doctor 6, COPD). 
 
In summary at the end of phase 3, the configuration of shared leadership was 
one in which doctors were pre-eminent influencers of innovation diffusion, nurses 
had enhanced their leadership influence through engagement and adaption activity, 
and managers had ceded leadership to doctors albeit the former continued to 
influence innovation diffusion in the background.   
 
Contextual influences upon shared leadership 
The empirical analysis above highlights how leadership was shared over 
time across three groups of actors in the COPD innovation project. We focused 
upon COPD as the project site within which diffusion of innovation was most 
extensive of all sites. This begs the question: What were the contextual influences at 
play that supported this. Table 3 provides a summary of case comparision. 
 
----------------------------------------------  
Insert Table 3 Here  
  
----------------------------------------------  
   
Table 3 highlights three contextual dimensions that impact shared leadership. 
Managerial dominance in leadership is derived in organizational contexts, first, 
where there exist financial challenges. In these situations, top down performance 
management of the innovation project is prevalent, a more transactional approach 
that drives out leadership influence from others. In the quote below, the hospital 
within which the doctor was employed, was under pressure from government 
agencies regarding its financial deficit, following which hospital management 
required that cost savings resulted from the CHF innovation, and these clearly 
accrued to the hospital rather than the healthcare system more generally, and that 
such cost savings could be realized in the short-term. Managerial demands for this 
caused doctors to rein back their leadership of the innovation project.   
 
 
The hospital managers threatened to pull my funding if I didn’t respond to 
their indicators for financial performance , at which point I just about got to 
the point of telling him to ‘do one’ and to pull it because I was sick of him 
(Senior Doctor 1, CHF) 
 
 
That the contingency of the financial situation shapes shared leadership for diffusion of 
innovation  is confirmed in Table 3, where the financial situation in the COPD case (Q1) 
stands in stark contrast to the financial situation and its ensuing management in the HIV case 
(Q2).   
  
Second, shared leadership is stymied amongst the ranks of nurses where they fail to enact 
the leadership role expected of them. Instead some nurses cast as leaders, remain orientated 
towards their clinical duties and fail to enact leadership towards engaging the frontline and 
adapting the innovation to fit with context, so that diffusion of innovation is limited.   
[Name of senior executive] demanded clinical outcomes and other things, 
and he said to all of staff that it’s mandatory, but saying that it’s mandatory 
meant the senior nurse didn’t really follow it up. She just paid lip service to 
the innovation and got on with managing the day-to-day stuff (Senior Doctor 
1, HIV) 
 
They [managers] really struggled with getting buy in from us, the senior 
nurses. I think there needed to be something more tangible of relevance for 
us, to emphasize why innovation is this important to engage us in its 
leadership (Nurse Project Manager 1, Diabetes). 
 
Again, we can see a contrast between the COPD case (Q3) and the HIV case (Q4) in Table 3, 
with the senior nurse enacting a leadership role towards innovation in the former, but 
orientating towards their clinical delivery duties in the latter.   
Third, we see managerial leadership dominant where organization is less collaborative 
than is desirable to support shared leadership. In one healthcare provider, the culture was 
autocratic, in another leadership was concentrated at the apex of the organization, with 
consequent deleterious effect upon shared leadership for diffusion of innovation.   
I must say that the management style was quite autocratic and wasn’t 
sensitive to the voices of people who were actually supposed to be 
  
collaborating in innovation. As a consequence it didn’t take off  (Senior 
Doctor 1, CAP). 
 
[Talking about two senior managerial leaders] Both like to have their 
fingers in all the pies and like to have control over what’s happening and so 
that discourages innovation because often I’ve been in a situation where I 
have hesitated or stalled because I’m waiting for senior management to say 
yes or no and that isn’t conducive to distribution of leadership  (Senior 
Doctor 1, Diabetes). 
 
Whether organization was hierarchical or collaborative was particularly evident in the 
workshops. Evident in Table Three, across COPD healthcare providers, the workshops 
engendered a collaborative ethos supportive of shared leadership for diffusion of innovation 
(Q5), whereas hierarchical leadership tendencies were were evident in workshops across 
CHF healthcare providers with a consequent deleterious effect upon shared leadership for 
diffusion of innovation (Q6).   
Discussion  
Empirically, our study highlights diffusion of innovation emerges as a result of shared 
leadership, within which hierarchical tendencies are encompassed (Holm and Fairhurst, 
forthcoming) and that appears performed in a particular sequence or in parallel (Spillane, 
2005), as shown in Figure One.  
 
-- Insert Figure One About Here: Configuration of Leadership in Innovation Diffusion -- 
Our study shows how, as diffusion of innovation ensues, leadership is shared across 
managers and professionals. Figure One simplifies a complex process and represents the 
  
interdependence of our key leadership actors (e.g. managers, doctors and nurses) with a focus 
upon their leadership influence that reveals how leadership is shared during innovation 
diffusion. On the one hand, it might still be argued that managerial leadership is important 
through developing an organizational context that encourages innovation (Anderson and 
West, 1998  Jung et al., 2003; McNally et al., 2013; Mumford, 2000; Mumford et al., 2002; 
Smith and Tushman, 2005), since the MHI is an organization set up by, and populated by 
managers in the first instance that sets out to promote innovation and its spread across a 
regional healthcare ecosystem. Hence the leadership practices of managers, to mandate 
innovation, to encourage agency amongst frontline professionals, build capacity in others 
through the development of an educational programme, and garner resource through 
influence with commissioners and other partners, is necessary and welcomed, particularly in 
the early phase of innovation diffusion (Currie and Spyridonidis, 2015).  
On the other hand, in professional organizations, over time, leadership for diffusion of 
innovation was passed to doctors with understanding of context and legitimacy to influence 
others, acting as champions to engage professional peers and influence partners, such as 
commissioners to resource innovation (Dopson et al., 2002). The shared leadership efforts of 
managers and doctors are similar and build on each other with respect to building capability 
for innovation amongst frontline professionals through education and  influencing 
commissioners and other partners that might allocate resource for innovation.  So over time, 
MHI managers enact more of a diplomat role (Giaimo, 2002) as doctors take on the baton of 
leadership. As they do so, doctors play a significant role in adapting the innovation to ensure 
it fits with routines and practices in its new context.  
In a similar fashion, our study highlights how nurses complement the leadership efforts of 
doctors. While commonly subordinate to doctors (Currie and Procter, 2005), nevertheless, 
over time nurses enact key leadership practices that both engage frontline professionals and 
  
so mediate potential resistance to innovation, and at the same time, adapt innovation as it 
diffuses to fit with exigencies of local context. In this adaptation endeavour, they work 
closely with those doctors adopting the innovation. Thus, over time, as innovation diffuses, 
the leadership role of managers, doctors and nurses, moves towards a more shared leadership 
configuration (Denis et al., 2012; Pearce and Conger, 2003).  
Shared leadership for diffusion of innovation was particularly evident in the COPD 
innovation case, but less evident in other cases; i.e. where innovation diffused across fewer 
healthcare providers. Our empirical analysis suggests, first, variation in financial performance 
of the hospitals explains less sharing of leadership for diffusion of innovation. This is 
consistent with extant literature (Currie and Spyridonidis, 2015; Spyridonidis and Currie, 
2016). In a situation of financial constraint for example, managers may prove to be pre-
eminent actors, and so stymie the enactment of shared leadership necessary for diffusion of 
innovation.  Second, whether those nurses expected to enact leadership alongside their 
clinical duties, ‘hybrid’ leaders, do so explains variation in diffusion of innovation (Croft et 
al., 2015a; 2015b). Third, we cannot assume that managerial-professional relations are good. 
Commonly, tension characterized in managerial-professional relations (Raelin, 1985), thus 
potential for the different actors to bring different capabilities to diffuse innovation is never 
realized. Similarly, nurse leader capabilities may never be realised in diffusion of innovation 
because they are rendered subordinate to doctors (Lockett et al., 2014). What we see in the 
‘success’ case of COPD case is more collaborative community as advocated by  Adler et al., 
(2015) amongst others (see also Adler, Kwon and Heckscher, 2008; Heckscher and Adler, 
2006; Irvine, 1999; Mitchell and Ream, 2015), free of managerial-professional tensions and 
inter-professional hierarchy.  
Conclusion 
  
Theoretically, our study extends recent studies regarding shared leadership for diffusion of 
innovation (Fitzgerald et al., 2002, 2013; Greenhalgh et al., 2004; Martin et al., 2013). Our 
study highlights who leads within different phases of innovation diffusion and how they lead 
(Empson and Langley, 2015; Fitzgerald et al., 2013; Greenhalgh et al., 2004).Within a 
professionalized context, first, our study confirms the co-existence of hierarchical and shared 
leadership (Holm and Fairhurst, forthcoming) during innovation diffusion with doctors 
emerging as key actors, but with managers remaining as important leadership actors because 
they have access to, and are accountable for, resources allocated to innovation (Currie and 
Lockett, 2011).  
Second, our study highlights a temporal dimension to the dynamic of leadership 
configurations for innovation diffusion, which thus far have been under-emphasized (Chreim 
2015; Gronn, 2015; Holm and Fairhurst, forthcoming; White, Currie and Lockett, 2016).   In 
doing so, we note an ongoing and dynamic blending of leadership actors and leadership 
practices as they relate to not just adoption of innovation, but its adaption to local context as 
it diffuses with those closer to the frontline, such as nurses, crucial to such adaption (Hartley 
and Benington, 2010; Rosing, Frese and Bausch, 2011). 
Third, rather than managerial dominance in diffusion of innovation, our study shows how, 
at least in professionalized settings, managers need to exhibit leadership ambidexterity 
(Bledow, Frese, and Mueller, 2011; Rosing, Frese and Bausch, 2011), and switch towards a 
facilitating ‘diplomat’ role (Giaimo, 2002) as diffusion of innovation progresses.  
Fourth, our study extends our understanding of shared leadership practice as it relates to 
adaption of innovation as it diffuses in professionalized settings (Ferlie et al., 2005; 
Fitzgerald et al., 2002; Kimberly and Evanisko, 1981; Martin et al., 2013; Mathers, Taylor 
and Parry, 2014; Rodriguez et al., 2016).  In contrast to existing studies, in our study, 
professional hierarchy was mediated as nurses, commonly characterized as subordinate to 
  
doctors (Currie and Procter, 2005), enacted a key leadership role that complemented doctors’ 
efforts to engage others and adapt innovation as it diffused. Indeed it might be argued that the 
nurses’ leadership role in adaption was more significant than that of doctors.  
Finally, our study responds to calls for more contextualized understandings of leadership 
dynamics (Liden and Antonakis, 2009). Our study highlights the effect of organizational 
financial performance  (Currie and Spyridonidis, 2015; Spyridonidis & Currie, 2016), 
enactment of hybrid leadership (Croft et al., 2015a; 2015b), and existence of hierarchical or 
collaborative organization (Adler et al., 2015; Adler, Kwon and Heckscher, 2008; Heckscher 
and Adler, 2006; Irvine, 1999; Mitchell and Ream, 2015) upon shared leadership for 
diffusion of innovation.  
Regarding transferability of analysis and future research, we emphasize the exemplary 
nature of our study setting with lessons likely to transfer to other research contexts in 
professionalized settings. Notwithstanding our assertion, we recognize the healthcare setting 
is rather distinctive in terms of plural organizational objectives shaped by professional and 
organizational goals (FitzGerald et al., 2002), and the myriad of professions arranged in a 
hierarchical relationship (Abbott, 1988). Consequently, we encourage others to pursue a 
similar research agenda focused upon the contextual understanding of leadership, how is 
leadership enacted on the ground in other public professionalized settings, including private 
sector organizations (e.g. law, accountancy). Of the three contingencies we identified as 
shaping shared leadership for diffusion of innovation, organizational form appears 
particularly intriguing to examine further, with managerial-professional relations remaining 
tense in many organizations, yet with emerging calls for more collaborative community. 
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 Table 1: Summary of innovation projects and fieldwork 
Innovation 
case 
Case 
description 
Extent of 
innovation 
diffusion  
Interviewees Total 
number of 
interviews 
with doctors 
and other 
clinicians 
  
Observation Documentation 
Mental 
health 
To introduce a 
new community 
clinic that aims to 
improve access to 
mental health & 
rapid assessment 
& diagnosis 
Diffused from 
its originating 
site to three 
other hospitals 
in the city 
 
Senior Doctor; 2 Specialist 
Nurses; 2 Psychotherapists; 
Nurse Project Manager 
 
 
13 
 
1 MHI training 
workshop 
(3hrs) 
 
Annual report summarizing 
implementation progress (1) 
Stroke Introduce a new 
educational 
intervention to 
improve the 
provision of  
secondary 
prevention 
information & life 
style change for 
minor stroke 
patients 
Diffused from 
its originating 
site to four 
other hospitals 
in the city 
 
Senior Doctor; 2 Specialist 
Nurses; Nurse Project Manager; 
Senior Occupational Therapist 
 
12 
 
3 meetings 
between MHI 
managers & 
project team 
(4.5hrs) 
 
Annual report summarizing 
implementation progress (1) 
 
Meetings minutes (3) 
 
HIV To assess the 
feasibility & 
acceptability of a 
new  
HIV test in the 
Emergency 
Diffused from 
its originating 
site to four 
other hospitals 
in the city 
 
Senior Doctor; Nurse Project 
Manager; 2 Junior Doctors 
 
7 
 
1 MHI training 
workshop (3hrs) 
 
Annual report summarizing 
implementation progress (1) 
 Department (ED) 
& the 
 community. 
 
Acute 
diabetic foot 
Develop a new 
community 
service to 
Improve 
management of 
acute diabetic 
foot 
Diffused from 
its originating 
site to six 
other hospitals 
in the city 
 
Senior Doctor; Nurse Project 
Manager; Physiotherapist; 2 
Junior Doctors 
 
 
15 
 
2 meetings 
between MHI 
managers & 
project team (4 
hrs) 
 
Annual report summarizing 
implementation progress (1) 
 
Meetings minutes (2) 
 
 Diabetes Introduce a new 
educational 
intervention to 
improve diabetes 
self-management, 
by raising 
awareness about 
diabetes; the risk 
factors in 
contracting 
diabetes; how 
people can test 
for diabetes 
Diffused from 
its originating 
site to six 
other hospitals 
in the city 
 
Senior Doctor; 2 Specialist 
Nurses; Nurse Project Manager; 
Physiotherapist 
 
 
12 
 
1 MHI 
training 
workshop 
(3hrs) 
 
Annual report summarizing 
implementation progress (1) 
Community 
acquired 
pneumonia 
(CAP) 
Introduce a new 
pathway to 
improve accurate 
clinical CAP 
diagnosis  
& increase 
reliability of 
outcome data.  
Diffused from 
its originating 
site to six 
other hospitals 
in the city 
 
Senior Doctor; 2 Nurse 
Specialists; Nurse Project 
Manager; 3 Junior Doctors 
 
13 
 
1 meeting 
between MHI 
managers & 
project team 
(1.5hrs) 
 
Annual report summarizing 
implementation progress (1) 
 
Meetings minutes (1) 
 
  
Chronic 
heart failure 
(CHF) 
Introduce a new 
clinic to 
encourage 
patients with 
heart failure to 
exercise. 
Diffused from 
its originating 
site to seven 
other hospitals 
in the city 
 
Senior Doctor; Specialist Nurse; 
Occupational Therapist; Nurse 
Project Manager 
 
 
9 
 
2 MHI 
training 
workshops 
(6hrs) 
 
Annual report summarizing 
implementation progress (1) 
  
Case 
management 
 
To assess whether 
protocol-driven 
case 
management for 
patients with 
complex disease 
profiles improves 
patient outcomes 
 
Diffused from 
its originating 
site to seven 
other hospitals 
in the city 
 
Senior Doctor; Nurse Project 
Manager; 2 Social Workers 
 
7 
-  
Annual report summarizing 
implementation progress 
Medicines 
management 
New service that 
aims improve 
medication 
management 
at discharge from 
acute medical 
care through 
improved 
medication 
reconciliation in 
line with  
national 
recommendations 
Diffused from its 
originating site 
to nine other 
hospitals in the 
city 
 
3 Senior Doctors; Nurse Project 
Manager; 3 Junior Doctors 
 
 
14 
 
1 meeting 
between MHI 
managers & 
project team 
(3hrs) 
 
2 MHI 
training 
workshop 
(3hrs) 
 
Meeting minutes (3) 
 
Annual report summarizing 
implementation progress (2) 
 
Antibiotic 
prescribing 
Develop a new 
policy to feedback 
on the quality of 
antibiotic use 
across an 
organisation 
Diffused from 
its originating 
site to 12 
other 
hospitals in 
the city 
 
Senior Doctor; Senior 
Pharmacist; Chief of Service 
(Pharmacy); 3 Junior Doctors 
 
 
18 
 
2 meetings 
between MHI & 
project team 
(3hrs) 
 
 
Meetings minutes (2) 
 
Annual report summarizing 
implementation progress 
 
 1 MHI training 
workshop (3hrs) 
 
Allergy To create an 
integrated allergy 
pathway for 
children across 
primary & 
secondary care.  
 
Diffused from 
its originating 
site to 12 
other 
hospitals in 
the city 
 
3 Senior Doctors; 3 Specialist 
Nurses 
 
10 
 
2 MHI training 
workshops 
(9hrs) 
 
Annual report summarizing 
implementation progress (2) 
 
Executive summaries to 
inform the 
commissioners of 
progress of the project 
(2) 
 
Chronic 
obstructive 
pulmonary 
disease 
 (COPD) 
Introduce a new 
pathway to 
improve the safe 
discharge of 
patients 
& improve patient 
experience. 
 
Diffused from 
its originating 
site to 15 
other 
hospitals in 
the city 
 
12 Senior Doctors; 3 Specialist 
Nurses; 3 Nurse Project 
Managers 
 
 
32 
 
3 MHI 
training 
workshops 
(12hrs) 
 
Annual reports summarizing 
implementation progress (3) 
 
Executive summaries to 
inform the commissioners of 
progress of the project (2) 
  
 
 
 
 
  
  
Table 2: Dynamics of leadership practices for innovation diffusion across comparative cases 
 
Leadership practice Year 2 Year 3 Year 4 Exemplary data excerpt Outcome 
Managers      
 
Providing mandate for 
innovation 
 
X 
 
 
X 
 
 
 
 
“My role is cultivating a culture that supports innovation” (MHI Manager 7). 
 
 
Encouraging agency amongst 
professionals towards 
innovation 
 
Developing educational 
programme for innovation 
 
X 
 
 
X 
 
X 
 
“The series of bespoke learning events that draw in all local health providers 
in our area are very, very powerful in terms of scaling up the projects, 
building the rationale for innovation amongst doctors, advising them about 
implementation” (MHI Manager 7). 
 
 
Building capability for 
innovation amongst 
professionals 
 
Influencing commissioners & 
other partners towards 
innovation 
 
X 
 
 
X 
 
X 
 
“From the commissioning perspective, there are so many changes happening 
across the sectors? Is it this, that, and the other? Who do we need to 
influence changes every week, so it’s just keeping up with that. And then it’s 
about cultivating those relationships. The doctors rely on us for this” (MHI 
Manager 3). 
 
 
Garnering resource for 
innovation 
Doctors      
 
Promoting innovation to 
commissioners 
 
X 
 
 
X 
  
“The reason why commissioners got interested, is because [name of local 
medical leader] got involved in it, we’re promoting that idea to them, day in 
and day out and we couldn’t do that without the support of our local clinical 
champions” (MHI Manager 9, commenting on Stroke case). 
 
 
Garnering resource for 
innovation 
 
Presenting evidence & best 
practice to peers through 
networks 
  
X 
 
X 
 
“In fact, on Monday, [name] and I are going to see the senior clinicians, two of 
them, one for children and one for adults in [name of hospital] and try and 
bring them in, quite powerful people that we want involve in scale up of the 
project” (Senior Doctor 2, Allergy). 
 
Engaging peers in diffusing 
innovation, whom adapt 
innovation 
  
 
Adopting doctors adapt 
innovation 
  
X 
 
 
X 
“[name of doctor] has it sold and championed all the way through we take 
practical things and say they’re not working so we’re going to adapt 
them”(Senior Doctor 5, COPD). 
 
Ensures innovation 
diffusion is less sticky 
Nurses      
 
Ensuring frontline support for 
innovation 
  
X 
 
X 
“You’ve got a whole organic system that needs to act differently or to change the 
way it’s working it’s a massively challenging area, but it’s also about really 
grounding that in the practical… pragmatic issues of frontline staff face, and for 
me, I mean it’s about people and it’s about methods and processes. It’s about 
getting the right people around the table, um, and getting frontline staff (Nurse 
Project Manager 1, Diabetes). 
 
 
Counters potential resistance to 
innovation on the frontline 
 
Adapting innovation to local 
context 
  
X 
 
 
X 
“[The way we work, you know is  to support routine implementation or the 
administrative infrastructure to facilitate innovation, you know, audit on 
demand or whatever, understand what works and what doesn’t work and 
that’s what you do and that’s part of, of continuous quality improvement or 
whatever process you want to call it to be responsive to local health need 
(Nurse Project Manager 1, Medicines Management) 
 
Ensures diffusion of innovation 
is less sticky 
 
 
 
  
 Table 3: Contextual influences upon shared leadership   
 
 
 Chronic obstructive 
pulmonary disease 
(COPD) 
HIV Community 
acquired 
pneumonia (CAP) 
Chronic heart 
failure (CHF) 
Quotes 
Diffusion success   Yes  No  No No   
 
 
Quote 1 (Q1) “Financially, it is an advantage, because we show a financial return in that financial 
year... so they[managers] are very enthusiastic, so they’re very much interested in employing 
more people for something that will have an impact in the short term .. so we work together” 
(Senior Doctor 5, COPD) 
 
Q2. “That’s something that we’re acutely aware of and if you’re asking for a weakness, we can’t 
resolve the financial stuff, so I think they [managers] want to have a framework around what 
we're doing so we don’t respond” (Senior Doctor 1, HIV) 
 
Financial 
performance 
Strong  Unsuccessful 
financial 
performance  
 
Shared leadership 
stymied 
 
Managerial 
leadership 
dominates 
 
  
Hybrid roles Present   Nurses did not 
successfully 
transition into 
hybrid leadership 
roles 
 
Shared leadership 
stymied 
 
Managerial 
leadership  
dominates 
 Q3. That I really liked what the they [CLAHRC] offered which was a bridging role between 
management and the frontline and what I would seek with my role and beyond would be to 
continue to function in that bridging role to both work with frontline staff and get change 
implemented and work with social media to help them implement change but also roll it out 
more broadly” (Specialist Nurse 3, COPD) 
 
Q4. “I was frustrated because I felt I had a clear purpose on this dual role of doing both 
innovation and clinical work, but I I didn’t feel the rest of the team saw me that way. I think, 
especially my line manager is very focused on clinical delivery and he wanted me to deliver and 
he would say you should support innovation, but he wouldn’t actually put anything in place to 
allow that to happen. He would just vaguely want it while also expecting me to heap my plate 
high with all these things I had to deliver. So that was my frustration, why I was getting really 
frustrated with it because it has been going on for a while, but it never really quite worked out 
for the first year or so”. (Nurse Project Manager 1, HIV) 
 
Collaborative 
community 
Present     
Collaborative 
community as 
exhibited in 
workshops never 
emerged 
 
Managerial 
leadership  
Q5. “I do think these workshops are an opportunity to network, and there are people in the 
room that I can see are key people, and that I want to know and influence, and that’s one 
aspect of spreading successful project, bringing those people together in the room” (Senior 
Doctor 2, COPD) 
 
Q6. “It's an irritation that they [managers] are too much hands on. You know, when you get a 
grant to do improvement work, you say what you’re going to do and you say what your 
timeframe is going to be and then you agree when you’re going to report back to the funders at 
 dominates. 
 
intervals, usually not more frequently than six or 12 months. However [name of managers] 
want reporting week by week, month by month; so called workshops, which are just reporting 
mechanisms, incredibly frequently. And for somebody like me  who’s got a fulltime job and lots 
of other things to do, that really is intrusive. We want to get on with work but we don’t want to 
have to feed back so frequently because there's not much to say week by week. It doesn’t feel 
collaborative.” (Senior Doctor 1, CHF) 
 
 
  
 
Figure 1. Configuration of leadership in innovation diffusion.  
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